AbCellera Biologics (ABCL)
(Delayed Data from NSDQ)
$2.59 USD
-0.15 (-5.47%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $2.67 +0.08 (3.09%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/07/2024
Time: -- |
9/2024 | $-0.14 | 0.00% |
Earnings Summary
For their last quarter, AbCellera Biologics (ABCL) reported earnings of -$0.13 per share, beating the Zacks Consensus Estimate of $-0.15 per share. This reflects a positive earnings surprise of 13.33%. Look out for ABCL's next earnings release expected on November 07, 2024. For the next earning release, we expect the company to report earnings of -$0.14 per share, reflecting a year-over-year decrease of 40%.
Earnings History
Price & Consensus
Zacks News for ABCL
GSK (GSK) Tops Q2 Earnings and Revenue Estimates
ABCL: What are Zacks experts saying now?
Zacks Private Portfolio Services